{"title":"HCC: Immuntherapie und Antiangiogenese als TACE-Partner","authors":"F. Klein","doi":"10.1007/s15015-024-3762-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"393 ","pages":"38"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Im Fokus Onkologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s15015-024-3762-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0